ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

May 5, 1995

CCIRC Holds Groups To 1980 Spending Levels, But They May Get Even Less

January 9, 1981

In the Cancer Centers: Rosen Moves To City Of Hope

November 1, 2013

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

October 13, 2000

Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.

June 27, 2003

White House Proposes NCI Budget Cut Of $40 Million or FY2007; NIH Budget Flat. Cuts And Earmarks Threaten To Derail 2015 Goal, NCI Director Says; “We Are In Difficult Times.”

February 10, 2006